Hers vs TrimRx: Which GLP-1 Provider Is Better?

By Iacob Pastina, Independent Researcher

48 providers verified independently·Independent research·How we rank →

TrimRx beats Hers overall, scoring 8.3/10 vs 7.3/10. Choose Hers for women who want brand-name wegovy (injection or pill) at $149. Choose TrimRx for users who want affordable compounded glp-1s with transparent.

A side-by-side comparison of Hers and TrimRx covering pricing, scores, medication types, insurance, and more to help you decide.

Hers

#35 of 48

7.3/10

The women's health arm of Hims & Hers Health (NYSE: HIMS). In 2026 Hers signed a direct Novo Nordisk partnership adding FDA-approved Wegovy (pen and pill) at $149/mo and Zepbound via the Lilly partnership — alongside their existing compounded semaglutide and new compounded tirzepatide programs.

Visit Hers

Higher Rated

TrimRx

#7 of 48

8.3/10

Budget-friendly compounded GLP-1 provider with straightforward pricing and a focus on accessibility.

Visit TrimRx

Feature	Hers	TrimRx
Our Score	7.3/10	8.3/10
Starting Price	$199/mo	$199/mo
Medication Type	Both	Both
Insurance Accepted	No	No
Best For	Women who want brand-name Wegovy (injection or pill) at $149/mo via the 2026 Novo Nordisk partnership, or a compounded semaglutide option from a publicly traded telehealth brand	Users who want affordable compounded GLP-1s with transparent, all-inclusive pricing
Ranking	#35	#7

Pros & Cons Compared

Hers

Pros

+2026 Novo Nordisk partnership — FDA-approved Wegovy pen and Wegovy oral pill from $149/mo, one of the lowest brand-name GLP-1 prices on the market
+Zepbound access via the Lilly/Hims-Hers partnership announced 2026
+Publicly traded company (NYSE: HIMS) with strong financial backing and regulatory compliance
+Broader women's health platform — integrates weight loss with hormonal, skin, and wellness services

Cons

−Membership + medication are billed separately ($39 first month / $149 ongoing membership) — watch the all-in math
−Generic support experience — large patient volume means less personalized attention
−Compounded pricing starts at $199/mo but stepped pricing applies at higher doses
−Zepbound access priced at ~$1,899/mo (brand cash) via the Lilly partnership — read as access, not value

TrimRx

Pros

+$179/mo all-inclusive for compounded semaglutide — one of the lowest prices for a full-service program
+Onboarding takes under 15 minutes with same-day provider review for most applications
+Published patient reviews averaging 4.5+ stars across third-party platforms
+Free medication replacement if your shipment is lost or damaged in transit

Cons

−Compounded semaglutide only — no brand-name options and no tirzepatide (compounded or otherwise)
−No insurance billing, and no superbill provided for out-of-network reimbursement

Our Verdict

TrimRx edges out Hers with a score of 8.3/10 vs 7.3/10. Choose Hers if you want: women who want brand-name wegovy (injection or pill) at $149/mo via the 2026 novo nordisk partnership, or a compounded semaglutide option from a publicly traded telehealth brand. Choose TrimRx if you want: users who want affordable compounded glp-1s with transparent, all-inclusive pricing.

Still undecided? Editor's #1 Overall Pick

Embody

$299/mo · 7.3/10 · Compounded

If neither Hers nor TrimRx feels like the right fit, our overall #1 pick across all 48 GLP-1 telehealth providers is Embody — strongest balance of clinical oversight, transparent pricing, and verified availability.

Visit Embody→Read our full Embody review